Phi Wiegn
4Patents
2h-index
7Co-inventors
37Inventor score
Filing activity: Jan 22, 1993 → May 21, 2010
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5618665A | Enzymatic fluorometric assay for adenylate cyclase | Emerging Cross-Sectional Technologies | 64 | Expired |
| US5316907A | Enzymatic fluorometric assay for adenylate cyclase | Emerging Cross-Sectional Technologies | 58 | Expired |
| US7723293B2 | Methods for increasing capillary density and maintaining viability of microvascular cardiac endothelial cells using trk receptor ligands | Human Necessities | 0 | Active |
| US8853163B2 | Methods for increasing vascular density and maintaining viability of microvascular endothelial cells using trk receptor ligands | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.